Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
778.00
-5.35 (-0.68%)
BSENSE

Feb 06

BSE+NSE Vol: 1.88 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "778.00",
    "chg": -5.35,
    "chgp": "-0.68%",
    "dir": -1,
    "prev_price": "783.35",
    "mcapval": "6,981.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0LRU01027",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "1.88 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3821781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiPharmalabs_technicaldot_3821781.png",
        "date": "2026-02-05 08:05:16",
        "description": "Aarti Pharmalabs Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on weekly charts, despite mixed signals from key indicators such as MACD, RSI, and moving averages. This nuanced technical landscape, combined with the company’s recent performance metrics and market context, offers investors a complex but insightful view into its near-term prospects."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3820311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiPharmalabs_mojoScore_3820311.png",
        "date": "2026-02-04 10:11:15",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3819848",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiPharmalabs_technicaldot_3819848.png",
        "date": "2026-02-04 08:07:29",
        "description": "Aarti Pharmalabs Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish indicators. Despite a recent upgrade from a Strong Sell to a Sell rating, the stock’s technical parameters present a nuanced picture that investors should carefully analyse."
      },
      {
        "title": "When is the next results date for Aarti Pharmalabs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aarti-pharmalabs-ltd-3812133",
        "imagepath": "",
        "date": "2026-01-30 23:20:50",
        "description": "The next results date for Aarti Pharmalabs Ltd is scheduled for 09 February 2026...."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3810692",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiPharmalabs_technicaldot_3810692.png",
        "date": "2026-01-30 08:02:58",
        "description": "Aarti Pharmalabs Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance, as reflected by a combination of mixed signals from key technical indicators including MACD, RSI, and moving averages. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and momentum indicators suggest a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-3802924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiPharmalabs_mojoScore_3802924.png",
        "date": "2026-01-24 10:10:39",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Aarti Pharmalabs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarti-pharmalabs-ltd-fallingrising-3792454",
        "imagepath": "",
        "date": "2026-01-15 00:55:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Market Performance Outpaces Benchmarks</strong></p>\n<p>The stock has demonstrated robust gains over multiple time frames, significantly outperforming the broader market indices. Over the past week, Aarti Pharmalabs surged by 6.07%, while the Sensex declined by 1.86%. Similarly, the one-month return for the stock stands at 7.05%, contrasting with a 2.21% fall in the Sensex. Year-to-date, the stock has appreciated by 5.42%, whereas the benchmark index has dropped by 2.16%. Over the last year, the company’s shares have delivered a remarkable 21.59% return, more than double the Sensex’s 9.00% gain. This market-beating performance has likely contributed to the recent investor enthusiasm and price appreciation.</p>\n<p><strong>Positive Technical and Trading Indicators</strong></p>\n<p>On the ..."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-3789353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AartiPharmalabs_technicaldot_3789353.png",
        "date": "2026-01-12 08:04:12",
        "description": "Aarti Pharmalabs Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a recent uptick in price, the stock’s technical landscape remains complex, reflecting a blend of cautious optimism and lingering downside risks for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarti Pharmalabs Gains 2.61%: 4 Key Technical and Fundamental Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-gains-261-4-key-technical-and-fundamental-factors-driving-the-week-3788154",
        "imagepath": "",
        "date": "2026-01-10 11:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Jan:</strong> Mojo Grade downgraded to Strong Sell amid weak financials</p>\n                    <p><strong>6 Jan:</strong> Bearish momentum confirmed with technical downturn and price dip to Rs.730.00</p>\n                    <p><strong>8 Jan:</strong> Mildly bearish technical shift as price recovers to Rs.730.20</p>\n                    <p><strong>9 Jan:</strong> Strong volume surge lifts price to Rs.761.30 despite bearish signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.741.95</div></div>\n                    <div class=\"stat-item\"><div class=\"st..."
      }
    ],
    "total": 267,
    "sid": "1003784",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Tuesday February 10 2026 at 4:00 P.M. (IST) to discuss the Companys Q3-FY26 Financial Results.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025 2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The Fi",
      "datetime": "29-Jan-2026",
      "details": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter and nine-months ended December 31 2025 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Clarification With Respect To Increase In Volume",
      "datetime": "12-Jan-2026",
      "details": "Please find attached clarifciation with respect to increase in volume",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>50%</strong> dividend, ex-date: 15 Sep 25",
          "dt": "2025-09-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Aarti Pharmalabs Ltd falling/rising?

2026-01-15 00:55:12

Recent Market Performance Outpaces Benchmarks

The stock has demonstrated robust gains over multiple time frames, significantly outperforming the broader market indices. Over the past week, Aarti Pharmalabs surged by 6.07%, while the Sensex declined by 1.86%. Similarly, the one-month return for the stock stands at 7.05%, contrasting with a 2.21% fall in the Sensex. Year-to-date, the stock has appreciated by 5.42%, whereas the benchmark index has dropped by 2.16%. Over the last year, the company’s shares have delivered a remarkable 21.59% return, more than double the Sensex’s 9.00% gain. This market-beating performance has likely contributed to the recent investor enthusiasm and price appreciation.

Positive Technical and Trading Indicators

On the ...

Read full news article
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

02-Feb-2026 | Source : BSE

This is to inform you that the Earnings Conference Call for Investors and Analysts which would be a Group meet has been scheduled on Tuesday February 10 2026 at 4:00 P.M. (IST) to discuss the Companys Q3-FY26 Financial Results.

Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025 2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The Fi

29-Jan-2026 | Source : BSE

Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter and nine-months ended December 31 2025 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2025-26.

Clarification With Respect To Increase In Volume

12-Jan-2026 | Source : BSE

Please find attached clarifciation with respect to increase in volume

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

09 Feb 2026

stock-summary
DIVIDEND

Aarti Pharmalabs Ltd has declared 50% dividend, ex-date: 15 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available